BRIEF-Diasorin says FDA approves 1,25 Vitamin D By: Reuters: Company News December 16, 2014 at 04:40 AM EST * Receives FDA clearence on commercialization of 1,25 Dihydroxyvitamin D on its Liaison XL in US market Read More >> Related Stocks: Dow Industrials SPDR